In prostate cancer cells, xenografts, and clinical tumors, the direct activation of androgen receptor (AR)-mediated fatty acid elongase of very-long-chain fatty acid 5 (ELOVL5) has been shown [147]. The gene discussed is AR; the disease is prostate carcinoma.